Luise Graichen
Overview
Explore the profile of Luise Graichen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
1579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arora P, Zhang L, Nehlmeier I, Kempf A, Graichen L, Kreitz E, et al.
J Virol
. 2025 Jan;
99(2):e0123024.
PMID: 39791910
The naturally occurring mutation E484D in the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can render viral entry ACE2 independent and imdevimab resistant. Here, we investigated...
2.
Zhang L, Cheng H, Kruger N, Hornich B, Graichen L, Hahn A, et al.
PLoS Pathog
. 2024 Nov;
20(11):e1012653.
PMID: 39536058
The COVID-19 pandemic, caused by SARS-CoV-2, demonstrated that zoonotic transmission of animal sarbecoviruses threatens human health but the determinants of transmission are incompletely understood. Here, we show that most spike...
3.
Hoffmann M, Kleine-Weber H, Graichen L, Nehlmeier I, Kempf A, Moldenhauer A, et al.
J Virol
. 2024 Oct;
98(11):e0130524.
PMID: 39470207
Human-to-human transmission of the highly pathogenic Middle East respiratory syndrome coronavirus (MERS-CoV) is currently inefficient. However, there is concern that the virus might mutate and thereby increase its transmissibility and...
4.
Zhang L, Dopfer-Jablonka A, Cossmann A, Stankov M, Graichen L, Moldenhauer A, et al.
iScience
. 2024 May;
27(6):109904.
PMID: 38812550
In July/August 2023, the highly mutated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.2.86 lineage emerged and its descendant JN.1 is on track to become the dominant SARS-CoV-2 lineage globally....
5.
Zhang L, Dopfer-Jablonka A, Nehlmeier I, Kempf A, Graichen L, Calderon Hampel N, et al.
Vaccines (Basel)
. 2024 May;
12(5).
PMID: 38793739
Transmissibility and immune evasion of the recently emerged, highly mutated SARS-CoV-2 BA.2.87.1 are unknown. Here, we report that BA.2.87.1 efficiently enters human cells but is more sensitive to antibody-mediated neutralization...
6.
Zhang L, Kempf A, Nehlmeier I, Cossmann A, Richter A, Bdeir N, et al.
Cell
. 2024 Jan;
187(3):596-608.e17.
PMID: 38194966
BA.2.86, a recently identified descendant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2 sublineage, contains ∼35 mutations in the spike (S) protein and spreads in multiple countries....
7.
Arora P, Zhang L, Rocha C, Graichen L, Nehlmeier I, Kempf A, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430535
Recently, a recombinant SARS-CoV-2 lineage, XD, emerged that harbors a spike gene that is largely derived from the Omicron variant BA.1 in the genetic background of the Delta variant. This...
8.
Sidarovich A, Kruger N, Rocha C, Graichen L, Kempf A, Nehlmeier I, et al.
Viruses
. 2022 Nov;
14(11).
PMID: 36366573
The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) facilitates viral entry into host cells and is the key target for neutralizing antibodies. The SARS-CoV-2 lineage B.1.620...
9.
Arora P, Zhang L, Kruger N, Rocha C, Sidarovich A, Schulz S, et al.
Cell Host Microbe
. 2022 May;
30(8):1103-1111.e6.
PMID: 35588741
The Omicron variant of SARS-CoV-2 evades antibody-mediated neutralization with unprecedented efficiency. At least three Omicron sublineages have been identified-BA.1, BA.2, and BA.3-and BA.2 exhibits increased transmissibility. However, it is currently...
10.
Arora P, Kempf A, Nehlmeier I, Graichen L, Schulz S, Cossmann A, et al.
Cell Mol Immunol
. 2022 May;
19(9):1067-1069.
PMID: 35581351
No abstract available.